0.2195USD-4.57%Mkt Cap: 3.55M USDP/E: —Last update: 2026-06-01
Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap3.55M USD
Enterprise Value-6.38M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-10.96M USD
Revenue/Share—
Last Price0.2195 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees13
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.44
PEG—
EV/EBITDA0.55
EV/Revenue—
P/S—
P/B0.36
EPS (TTM)-0.95
EPS (Forward)-0.52
52W Range
0.10005% of range2.400
52W High2.400 USD
52W Low0.1000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-288.21%
ROA-218.00%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.22M USD
CapEx (TTM)186.06K USD
FCF Margin—
FCF Yield-187.74%
Net Debt-9.71M USD
Net Debt/EBITDA0.83
Balance Sheet
Debt/Equity0.11
Current Ratio6.94
Quick Ratio6.58
Book Value/Sh0.6470 USD
Cash/Share0.6210 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split15:100
Split DateAug 21, 2025
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)0.7750 USD
Target Range0.5500 USD – 1.000 USD
# Analysts2
Ownership
Shares Out.16.19M
Float16.18M
Insiders3.38%
Institutions3.33%
Short Interest
Short Ratio0.2d
Short % Float1.20%
Short % Out.0.78%
Shares Short126.54K
Short (prev mo.)557.16K
Technical
SMA 500.2251 (-2.5%)
SMA 2000.4109 (-46.6%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)588.48K
Avg Vol (10d)615.76K
Technical Indicators
RSI (14)57.2
MACD-0.0043
MACD Signal-0.0057
MACD Hist.+0.0014
BB Upper0.2628 USD
BB Middle0.2170 USD
BB Lower0.1712 USD
BB Width42.19%
ATR (14)0.0178 USD
Vol Ratio (20d)2.54x